© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle

News

November 20, 2017

Special Focus Issue of Future Oncology highlights advances in image guided therapy

The Future Science Group (FSG) published journal, Future Oncology, has released a special focus issue that examines the field of image guided therapy in oncology, highlighting the latest advancements in image guided therapy and the application of several techniques in a number of cancer types.

The issue was guest edited by Ron Allison (The Brody School of Medicine, USA) who stated: “Imagine a tumor lighting up for the surgeon to see. Imagine the oncologist able to precisely track and treat a cancer while it moves during an actual radiation therapy session. Imagine what the future of Oncologic intervention will mean to patients and caregivers when these types of imaging techniques become widespread. This issue of the Journal highlights current and future Image guided interventions in oncology. Truly, it appears that imaging and imagination go hand in hand.”

 

Highlights from the issue include a variety of review articles discussing a range of techniques and cancers including fluorescence and intraoperative image guided neurosurgery, and optical imaging for gastrointestinal surgery; a special report investigating the importance of image guided surgery such as the use of photodiagnosis and photodynamic therapy in endometrial and cervical cancer; and an editorial that highlights recent advances in radiotherapy, and examines what needs to be done in order to generate personalized, image-directed radiotherapy approaches that are available to all patients.

 

Rachel Jenkins, commissioning editor for Future Oncology commented: “We are delighted to publish this special focus issue which aims to highlight the vast progress made in several areas of image-guided cancer therapies. This issue will hopefully provide a platform for researchers and clinicians to discuss these developments in their respective specialist fields.”

 

The issue is available online here: https://www.futuremedicine.com/toc/fon/13/26

 

Allison’s foreword as guest editor is free to read, here: https://www.futuremedicine.com/doi/10.2217/fon-2017-0400

 

 

-ENDS-

 

 

About Future Oncology

 

Future Oncology is a MEDLINE-indexed journal, with an impact factor of 2.131. The journal covers the latest scientific and clinical issues, together with the economic and policy issues of relevance to oncologists. The journal delivers essential information in concise, at-a-glance article formats – vital in delivering information to an increasingly time-constrained community. http://www.futuremedicine.com/loi/fon

 

About Future Science Group

 

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research.  FSG’s portfolio includes two imprints, Future Science and Future Medicine.  In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

 

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs.  This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.